S. Kol

S. Kol, Tatiana Breizman, Linoy Segal, 2018, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

GnRH-agonist triggering for final oocyte maturation in GnRH-antagonist IVF cycles induces decreased LH pulse rate and amplitude in early luteal phase: a possible luteolysis mechanism

S. Tannus, C. McCartney, S. Kol, 2017, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

'Luteal coasting' after GnRH agonist trigger - individualized, HCG-based, progesterone-free luteal support in 'high responders': a case series.

P. Humaidan, S. Kol, Linoy Segal, 2015, Reproductive biomedicine online.

The updated Cochrane review 2014 on GnRH agonist trigger: repeating the same errors.

P. Humaidan, J. García-Velasco, C. Andersen, 2015, Reproductive biomedicine online.

The gonadotropin‐releasing hormone antagonist protocol – the protocol of choice for the polycystic ovary syndrome patient undergoing controlled ovarian stimulation

P. Humaidan, R. Homburg, S. Kol, 2012, Acta obstetricia et gynecologica Scandinavica.

Reproductive outcome of fresh or frozen-thawed embryo transfer is similar in high-risk patients for ovarian hyperstimulation syndrome using GnRH agonist for final oocyte maturation and intensive luteal support.

T. Imbar, S. Kol, F. Lossos, 2012, Human reproduction.

HCG: Is it the Best Choice for Ovulation Triggering?

E. Papanikolaou, P. Humaidan, D. Bodri, 2012 .

Should Cochrane reviews be performed during the development of new concepts?

E. Papanikolaou, P. Humaidan, C. Andersen, 2012, Human reproduction.

LH (as HCG) and FSH surges for final oocyte maturation: sometimes it takes two to tango?

P. Humaidan, S. Kol, 2010, Reproductive biomedicine online.

Gonadotropin-releasing hormone agonist trigger: the way to eliminate ovarian hyperstimulation syndrome--a 20-year experience.

J. Itskovitz‐Eldor, S. Kol, 2010, Seminars in reproductive medicine.

GnRH agonist for triggering final oocyte maturation in patients at risk of ovarian hyperstimulation syndrome: still a controversy?

I. Solt, S. Kol, 2008, Journal of Assisted Reproduction and Genetics.

'GnRH agonist trigger: looking for the coin under the lamp post?'.

S. Kol, 2006, Human reproduction.

Agonist trigger in the context of OHSS prevention: primum non nocere.

S. Kol, 2006, Human reproduction update.

Endocrinology: Comparison of gonadotrophin-releasing hormone analogues and human chorionic gonadotrophin for the induction of ovulation and prevention of ovarian hyperstimulation syndrome: a case-control study

J. Itskovitz‐Eldor, S. Kol, D. Manor, 1996 .

The exogenous progesterone-free luteal phase: two pilot randomized controlled trials in IVF patients.

P. Humaidan, T. Haahr, S. Kol, 2021, Reproductive biomedicine online.

Luteal phase support post IVF: individualized early stop.

S. Kol, Linoy Segal, Tatiana Breyzman, 2015, Reproductive biomedicine online.

Time, time, time: see what governs the luteal phase endocrinology

S. Kol, 2021, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

The Role of GnRH Agonist Triggering in GnRH Antagonist-Based Ovarian Stimulation Protocols

O. Fainaru, S. Kol, 2019, The Ovary.

A Rationale for Timing of Luteal Support Post Gonadotropin-Releasing Hormone Agonist Trigger

S. Kol, 2018, Gynecologic and Obstetric Investigation.

GnRH Agonist Triggering of Ovulation Replacing hCG: A 30-Year-Old Revolution in IVF Practice Led by Rambam Health Care Campus

O. Fainaru, S. Kol, 2017, Rambam Maimonides medical journal.

GnRH agonist trigger does not always cause luteolysis: a case report.

S. Kol, Tatiana Breyzman, 2016, Reproductive biomedicine online.

Symposium: Update on prediction and management of OHSS. Prevention of OHSS: GnRH agonist versus HCG to trigger ovulation.

J. Dor, S. Kol, 2009, Reproductive biomedicine online.

Luteal support post GnRH agonist trigger: do not stop too soon.

S. Kol, 2005, Human reproduction.

Does ovulation triggering influence the risk for ovarian hyperstimulation syndrome

S. Kol, 2005 .

Use of Gonadotropin-Releasing Hormone Agonist to Cause Ovulation and Prevent the Ovarian Hyperstimulation Syndrome

J. Itskovitz‐Eldor, J. Levron, S. Kol, 1993, Clinical obstetrics and gynecology.

Assisted Reproductive Technology (ART)

Shahar Kol, S. Kol, 2004 .

Recombinant gonadotrophin-based, ovarian hyperstimulation syndrome-free stimulation of the high responder: suggested protocol for further research.

S. Kol, Mira Muchtar, 2005, Reproductive biomedicine online.

A case of severe early-onset OHSS after GnRH-agonist triggering.

S. Kol, 2011, Fertility and sterility.

The presence of a sponsoring embryo in a batch of poor quality thawed embryos significantly increases pregnancy and implantation rate.

J. Itskovitz‐Eldor, A. Lightman, S. Kol, 1997, Fertility and sterility.

Infertility in intracytoplasmic-sperm-injection-derived sons

J. Itskovitz‐Eldor, S. Blazer, S. Kol, 1996, The Lancet.

Human embryonal extracts modulate placental function in the first trimester: effects of visceral tissues upon chorionic gonadotropin and progesterone secretion.

R. Simon, E. Barnea, S. Kol, 1989, Placenta.

The Importance of Mid-Follicular Phase Luteinizing Hormone Rise in GnRH Antagonist-Based Ovarian Stimulation for IVF

R. Beck-Fruchter, S. Kol, Linoy Segal, 2020, Gynecologic and Obstetric Investigation.

Undocumented embryos: do not trash them, FISH them.

J. Itskovitz‐Eldor, A. Lightman, D. Stein, 1996, Human reproduction.

The natural history of multiple pregnancies after assisted reproduction: is spontaneous fetal demise a clinically significant phenomenon?

J. Itskovitz‐Eldor, J. Levron, A. Drugan, 1993, Fertility and sterility.

Intraovarian factors regulating ovarian function.

E. Adashi, S. Kol, 1995, Current Opinion in Obstetrics and Gynecology.

Triggering Ovulation with GnRH Analogs

J. Itskovitz‐Eldor, S. Kol, 2000 .

The use of GnRH analogs for induction of the preovulatory gonadotropin surge in assisted reproduction and prevention of the ovarian hyperstimulation syndrome

J. Itskovitz‐Eldor, S. Kol, D. Manor, 1995 .

The rat ovarian phospholipase A2 system: gene expression, cellular localization, activity characterization, and interleukin-1 dependence.

E. Adashi, I. Ben-Shlomo, D. Payne, 1997, Endocrinology.

Should we explore OHSS full clinical scope?...

S. Kol, 2001, Human reproduction.

Ovarian interleukin-1 receptor antagonist in rats: gene expression, cellular localization, cyclic variation, and hormonal regulation of a potential determinant of interleukin-1 action.

E. Adashi, I. Ben-Shlomo, M. Irahara, 1999, Biology of reproduction.

To add or not to add LH: consideration of LH concentration changes in individual patients.

S. Kol, 2005, Reproductive biomedicine online.

Individualized Treatment from Theory to Practice: The Private Case of Adding LH during GnRH Antagonist-based Stimulation Protocol

S. Kol, 2014, Clinical medicine insights. Reproductive health.

Change, change, change: hormonal actions depend on changes in blood levels.

R. Homburg, S. Kol, 2008, Human reproduction.

LH Supplementation in Ovarian Stimulation for IVF: The Individual, LH Deficient, Patient Perspective

S. Kol, 2020, Gynecologic and Obstetric Investigation.

Suboptimal response to GnRH agonist trigger: causes and practical management

P. Humaidan, S. Kol, 2021, Current opinion in obstetrics & gynecology.

Ultrasound-guided embryo transfer--a special role in patients with certain uterine defects.

S. Kol, 2008, Fertility and sterility.

Embryo implantation and GnRH antagonists: GnRH antagonists in ART: lower embryo implantation?

S. Kol, 2000, Human reproduction.

High doses of gonadotrophin-releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze-thaw cycles.

J. Itskovitz‐Eldor, B. Tarlatzis, P. Devroey, 1999, Human reproduction.

Assisted implantation: direct intraendometrial embryo transfer.

J. Itskovitz‐Eldor, A. Lightman, D. Stein, 1997, Gynecologic and obstetric investigation.

GnRH agonist triggering followed by 1500 IU of HCG 48 h after oocyte retrieval for luteal phase support.

S. Kol, Linoy Segal, 2020, Reproductive biomedicine online.

A prospective randomized study comparing intramuscular with intravaginal natural progesterone in programmed thaw cycles.

J. Itskovitz‐Eldor, A. Lightman, S. Kol, 1999, Human reproduction.

Transforming growth factor-beta1 is a potent inhibitor of interleukin-1beta action in whole ovarian dispersates.

E. Adashi, I. Ben-Shlomo, C. Resnick, 1999, The Journal of endocrinology.

The Rat Ovarian Phospholipase A2 System: Gene Expression, Cellular Localization, Activity Characterization, and Interleukin-1 Dependence1.

E. Adashi, I. Ben-Shlomo, D. Payne, 1997, Endocrinology.

Ovarian interleukin-1-induced gene expression: privileged genes threshold theory.

E. Adashi, I. Kehat, S. Kol, 2002, Medical hypotheses.

Detection and In Vivo Hormonal Regulation of Rat Ovarian Type I and Type II Interleukin-I Receptor mRNAs: Increased Expression During the Periovulatory Period

E. Adashi, R. Rohan, S. Kol, 1996, The Journal of the Society for Gynecologic Investigation: JSGI.

Simplified riboprobe purification using translucent straws as gel tubes.

E. Adashi, I. Ben-Shlomo, R. Rohan, 1996, Genetic analysis : biomolecular engineering.

First established pregnancy after controlled ovarian hyperstimulation with recombinant follicle stimulating hormone and the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462).

J. Itskovitz‐Eldor, H. C. Coelingh Bennink, B. Mannaerts, 1998, Human reproduction.

Distinct and independent dielectrophoretic behavior of the head and tail of sperm and its potential for the safe sorting and isolation of rare spermatozoa

Sinwook Park, G. Yossifon, S. Kol, 2019, Electrophoresis.

Prediction of ovarian hyperstimulation syndrome: why predict if we can prevent!

S. Kol, 2003, Human reproduction.

How Many Embryos Should Be Transferred? The Relevance of Parity and Obstetric History.

O. Fainaru, S. Kol, 2016, The Israel Medical Association journal : IMAJ.

Ovarian hyperstimulation syndrome after using onadotrophin-releasing hormone analogue as a trigger of ovulation: causes and implications

S. Kol, J. ltskovitz-Eldor, N. Lewit, 1996 .

Detection and In Vivo Hormonal Regulation of Rat Ovarian Type I and Type II Interleukin-I Rececptor mRNAs: Increased Expression During the Periovulatory Period

E. Adashi, R. Rohan, S. Kol, 1996, Journal of the Society for Gynecologic Investigation.

Severe OHSS: yes, there is a strategy to prevent it!

J. Itskovitz‐Eldor, S. Kol, 2000, Human Reproduction.

The role of catecholamines in estradiol and progesterone secretion by cultured explants and cells of human term placentae.

Z. Hochberg, R. Perlman, E. Barnea, 1989, Acta endocrinologica.

Hormonal Therapy of the Infertile Woman

S. Kol, 2003 .

'Model' versus 'everyday' patients: can randomized controlled trial data really be applied to the clinic?

O. Fainaru, S. Kol, Linoy Segal, 2017, Reproductive biomedicine online.

Insulin-like growth factor I affects the intraovarian interleukin-1 system: evidence for suppression of type I interleukin-1 receptor expression and enhancement of secretory phospholipase A2 expression and activity.

E. Adashi, I. Ben-Shlomo, S. Kol, 1997, Molecular human reproduction.

GnRH agonist for triggering of final oocyte maturation: time for a change of practice?

E. Papanikolaou, P. Humaidan, S. Kol, 2011, Human reproduction update.

Insulin-like growth factor I affects the intraovarian interleukin-1 system : evidence for suppression of type I interleukin-1 receptor expression and enhancement of secretory phospholipase A 2 expression and activity

E. Adashi, I. Ben-Shlomo, S. Kol, 1997 .

The Role of Growth Factors in Ovarian Function and Development

E. Adashi, R. Rohan, S. Kol, 2009 .